Tepnel Pharmaceutical Services

April 6, 2010

As the best in class global provider of analytical services to the pharmaceutical sector, Tepnel Pharmaceutical Services specialises in the provision of regulatory services and analytical solutions, including cGMP drug development services, preclinical support services, clinical support services and molecular genetic services under inspection and approval of the MHRA and FDA.


Come and visit us

on Stand 49 at BioTrinity 2010, 12-14 April in Newbury, UK

, and talk to us about our Clinical/Preclinical and cGMP Development Services. For further information please contact us on +44 (0)1506 424 270 or email

pharmaservices@gen-probe.com

www.gen-probe.com

As the best in class global provider of analytical services to the pharmaceutical sector, Tepnel Pharmaceutical Services specialises in the provision of regulatory services and analytical solutions, including cGMP drug development services, preclinical support services, clinical support services and molecular genetic services under inspection and approval of the MHRA and FDA. Established for over 25 years, Tepnel Pharmaceutical Services has the experience to handle even the most complex of analytical methodologies, and is dedicated to continuously developing efficiencies on behalf of its clients. Tepnel Pharmaceutical Services is perfectly positioned to be your analytical partner of choice for all your early to late stage needs.

Tepnel Pharmaceutical Services is an established business of Gen-Probe Incorporated, a world leader in molecular diagnostics.

Product Profile:

If you need to transform your outsource experience then ask about our Pre/Clinical Support Services which consists of following;

PRECLINICAL SUPPORT SERVICESMethod development and validation
• In accordance with ICH and Crystal City recommendations, Methods developed on MS, HPLC, GC, IC and immunoassays.

Sample Analysis
• Independent Bioanalysis Laboratory
• Sample analysis for a full range of mammalian species

Support range of preclinical investigations
• GLP Toxicology Studies
• ADME
• Metabolism
• Pharmacokinetic
• Safety Pharmacology

CLINICAL SUPPORT SERVICESMethod development and validation
• In accordance with ICH and Crystal City recommendations, Methods developed on MS, HPLC, GC, IC and immunoassays.

Drug Metabolism and Pharmacokinetics
• Providing data in support of safety and efficacy

Phase I to Phase IV Clinical Support
• API detection in biological matrices, MS, UV/VIS, IC, immunoassay

Identification and quantification of Biomarkers
• Protein and genetic biomarker development

Pharmacogenomics
• Illumina CSpro provider/Affymetrix service provider